Alzheimer Disease and Related Dementias
7
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Treatment Research
10 treatments under study, led by Homebased Active Tdcs
Research Leaders
12 sponsors active, led by National Institute on Aging (NIA)
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
1 terminated out of 7 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
SmartEnLite for Nursing Home Residents With Dementia
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
Aligning Medications With What Matters Most
Promoting Positive Care Interactions (PPCI) in Assisted Living
MASC: Reducing Stress for Caregivers
Home-based tDCS for Apathy in Alzheimer's Disease
Research Network
Common Treatments
- Homebased Active Tdcs1
- Ppcistaff Education Only Eo1
- Promoting Positive Care Interactions Ppci1
- Smart Environmental Light Smartenlite1
- Activesham1
Active Sponsors
- National Institute on Aging (NIA)4
- Penn State University2
- Texas Alzheimer's Research and Care Consortium1
- Johns Hopkins University1
- The University of Texas Health Science Center, Houston1
Top Investigators
Johns Hopkins University
Penn State University
The University of Texas Health Science Center, Houston
Massachusetts General Hospital
Tel-Aviv Sourasky Medical Center
Related Conditions
- Alzheimers Disease And Related Dementias1
- Cognition1
- Dementia Alzheimers1
- Polypharmacy1
- Mobility Disability1